On December 8, 2022, closed the transaction. Starting December 9, 2022, the amount equivalent to 90% of the closing price rounded up to the nearest yen will be If the exercise price exceeds or falls below the immediately preceding effective exercise price by 1 yen or more, the exercise price will be revised to the revised price on or after the revision date. However, if the price after such revision falls below ¥457, the minimum exercise price shall be the revised exercise price.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
436 JPY | +0.23% | 0.00% | -16.48% |
1st Jan change | Capi. | |
---|---|---|
-16.48% | 48.05M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- 4572 Stock
- News Carna Biosciences, Inc.
- Carna Biosciences, Inc. announced that it has received ¥11.209315 million in funding from Cantor Fitzgerald & Co.